Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Get a quick snapshot of today’s dividend ETF expense ratios and what they mean for your potential returns, with tips for comparing funds.
18,562 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A near-retirement couple stands at the edge of an earlier exit from work. With $3.1 million, they must navigate a fiv...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...
ThredUp's chief argues that a permanent four-day workweek provides a competitive edge in attracting talent. The broad...
As markets heat up this summer, here's this tech stock stands out for its AI-focused growth story, solid finances, an...
Century 21 fuses its storied branding with Compass tech to revamp financing options and the buyer experience, aiming ...
Constant portfolio checks feel productive, but they often erode long-term gains. Learn why stopping the daily peek ma...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
BingEx reports Q1 2026 results that reveal both momentum and headwinds. This article breaks down the key numbers, exp...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
Rigetti Computing stock surged as government funding boosted optimism for quantum tech. Learn what happened, what it ...
If you're weighing two ad-tech stocks, this guide breaks down how to think about should zeta global stock versus AppL...